This content is not available in your region

EU regulator could issue decision on Pfizer COVID-19 pill 'within weeks'

Access to the comments Comments
By Reuters
EU regulator could issue decision on Pfizer COVID-19 pill 'within weeks'
EU regulator could issue decision on Pfizer COVID-19 pill 'within weeks'   -   Copyright  Thomson Reuters 2022

– The European Union’s drug regulator said on Monday it could issue “within weeks” a decision on whether to approve the use of Pfizer’s COVID-19 pill, Paxlovid, after the U.S. drugmaker submitted an application seeking authorisation.

The approval sought is for the treatment of mild-to-moderate COVID 19 in patients 12 years of age and older, weighing at least 40 kilograms and are at high risk of their illness worsening, the European Medicines Agency said.